Sun Pharma's generic Cymbalta gets tentative approval from FDA

11/28/2010 | Business Standard (India)

The FDA has issued tentative marketing approval for Sun Pharmaceutical Industries' duloxetine hydrochloride, a copy of Eli Lilly and Co.'s Cymbalta. The drug is used for treating generalized anxiety disorder, diabetic peripheral neuropathic pain and major depressive disorder. Sun will launch the generic product in 20-, 30- and 60-milligram capsules.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC